The global Human Milk Oligosaccharides Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (2’ FL, 3’ FL, 3’ SL, 6’ SL), By Application (Infant Formula, Functional Food & Beverages, Food Supplements, Others), By Concentration (Neutral, Acidic)
The human milk oligosaccharides (HMOs) market in 2024 is witnessing rapid growth, driven by increasing recognition of their unique health benefits, advancements in infant nutrition, and growing demand for functional ingredients. HMOs are complex carbohydrates naturally present in human breast milk, playing a crucial role in infant gut health, immune development, and cognitive function. With rising awareness of the importance of breastfeeding and the limitations of infant formula, there is growing interest in supplementing formula milk with HMOs to mimic the nutritional composition of breast milk. Moreover, scientific research highlighting the multifaceted health benefits of HMOs, such as prebiotic effects, anti-inflammatory properties, and pathogen inhibition, is driving market demand across diverse age groups and health applications. Additionally, advancements in biotechnology and fermentation processes are enabling the commercial production of HMOs from non-human sources, such as plants and microbial fermentation, to meet market demand sustainably. Furthermore, collaborations between HMO manufacturers, infant formula companies, and healthcare providers are driving product innovation, market penetration, and consumer education initiatives. Overall, the human milk oligosaccharides market is poised for continued expansion as manufacturers leverage their functional properties to develop novel nutritional solutions for various health conditions and life stages.
The market report analyses the leading companies in the industry including Abbott Laboratories, BASF SE, Biosynth Carbosynth, CHR Hansen A/S, Dextra Laboratories, DuPont de Nemours Inc, Elicityl S.A, Gnubiotics Sciences S.A, Inbiose N.V, Nestle S.A., Royal DSM N.V., Royal Friesland Campina N.V, and Others.
One prominent trend in the human milk oligosaccharides (HMOs) market is the increasing awareness of the health benefits associated with HMOs. As research continues to unveil the unique properties and functions of HMOs found in breast milk, there's a growing interest in leveraging these bioactive compounds for various health applications. HMOs have been linked to numerous health benefits, including immune system support, gut health promotion, and cognitive development, driving their incorporation into infant formula, dietary supplements, and functional foods targeting both infants and adults.
A key driver in the HMOs market is the rising demand for infant formula fortified with HMOs. With breastfeeding not always feasible or sufficient for all infants, there's a growing need for infant formulas that closely mimic the composition and benefits of breast milk. HMOs play a crucial role in this regard, as they are the third most abundant solid component in breast milk and are recognized for their role in supporting infant health and development. As parents seek optimal nutrition for their babies, there's increasing demand for infant formulas supplemented with HMOs to provide benefits similar to those of breast milk.
An emerging opportunity in the HMOs market is the expansion into functional food and beverage applications beyond infant nutrition. While HMOs have primarily been incorporated into infant formula, there's potential for their utilization in a broader range of products targeting various consumer segments. HMOs' beneficial effects on gut health, immune function, and microbiome modulation make them attractive ingredients for functional foods, beverages, and dietary supplements targeting adults and children. By exploring novel formulations and applications, manufacturers can capitalize on the growing interest in gut health and immune support among consumers, expanding the market for HMOs beyond infant nutrition.
In the landscape of human milk oligosaccharides (HMOs), 2’ FL (2’-fucosyllactose) is the largest segment, owing to its widespread presence in breast milk and significant health benefits. As one of the most abundant HMOs in human milk, 2’ FL plays a crucial role in supporting infant health by promoting the growth of beneficial gut bacteria, strengthening the immune system, and aiding in the development of cognitive functions. Further, research highlighting the potential therapeutic applications of 2’ FL in combating infectious diseases and inflammatory conditions further drives its demand in the pharmaceutical and nutraceutical sectors. With increasing consumer awareness of the importance of HMOs in infant nutrition and health, the demand for 2’ FL continues to escalate, solidifying its position as the dominant segment in the human milk oligosaccharides market.
Within the diverse applications of human milk oligosaccharides (HMOs), functional food and beverages emerge as the fastest-growing segment, driven by increasing consumer demand for products offering enhanced health benefits. HMOs, particularly 2’ FL and 3’ FL, are gaining traction as functional ingredients in a variety of food and beverage formulations due to their prebiotic properties and potential to support gut health and immunity. The incorporation of HMOs into functional foods and beverages aligns with evolving consumer preferences for natural and nutritious products, driving innovation in the food industry. Further, growing awareness among consumers about the importance of HMOs beyond infant nutrition fuels the demand for functional products enriched with these bioactive compounds. As manufacturers continue to introduce new HMO-fortified products targeting various health concerns, the functional food and beverage segment is poised for significant growth, reshaping the landscape of the human milk oligosaccharides market.
In the realm of human milk oligosaccharides (HMOs), the neutral concentration segment is the largest, driven by its prevalence in breast milk and extensive research highlighting its diverse health benefits. Neutral HMOs, such as 2’ FL and 3’ FL, are structurally similar to those found naturally in human milk, making them highly sought-after ingredients in infant formula and nutritional supplements. These neutral oligosaccharides play a crucial role in supporting infant health by promoting the growth of beneficial gut bacteria, strengthening the immune system, and aiding in the development of cognitive functions. Additionally, the increasing recognition of neutral HMOs' potential therapeutic applications in combating infectious diseases and inflammatory conditions further fuels their demand in the pharmaceutical and nutraceutical sectors. With consumers increasingly prioritizing natural and functional ingredients in infant nutrition and health products, the neutral concentration segment maintains its dominance in the human milk oligosaccharides market landscape.
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
BASF SE
Biosynth Carbosynth
CHR Hansen A/S
Dextra Laboratories
DuPont de Nemours Inc
Elicityl S.A
Gnubiotics Sciences S.A
Inbiose N.V
Nestle S.A.
Royal DSM N.V.
Royal Friesland Campina N.V
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Human Milk Oligosaccharides Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Human Milk Oligosaccharides Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Human Milk Oligosaccharides Market Share by Company, 2023
4.1.2. Product Offerings of Leading Human Milk Oligosaccharides Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Human Milk Oligosaccharides Market Drivers
6.2. Human Milk Oligosaccharides Market Challenges
6.6. Human Milk Oligosaccharides Market Opportunities
6.4. Human Milk Oligosaccharides Market Trends
Chapter 7. Global Human Milk Oligosaccharides Market Outlook Trends
7.1. Global Human Milk Oligosaccharides Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Human Milk Oligosaccharides Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Human Milk Oligosaccharides Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Chapter 8. Global Human Milk Oligosaccharides Regional Analysis and Outlook
8.1. Global Human Milk Oligosaccharides Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Human Milk Oligosaccharides Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Human Milk Oligosaccharides Regional Analysis and Outlook
8.2.2. Canada Human Milk Oligosaccharides Regional Analysis and Outlook
8.2.3. Mexico Human Milk Oligosaccharides Regional Analysis and Outlook
8.3. Europe Human Milk Oligosaccharides Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Human Milk Oligosaccharides Regional Analysis and Outlook
8.3.2. France Human Milk Oligosaccharides Regional Analysis and Outlook
8.3.3. United Kingdom Human Milk Oligosaccharides Regional Analysis and Outlook
8.3.4. Spain Human Milk Oligosaccharides Regional Analysis and Outlook
8.3.5. Italy Human Milk Oligosaccharides Regional Analysis and Outlook
8.3.6. Russia Human Milk Oligosaccharides Regional Analysis and Outlook
8.3.7. Rest of Europe Human Milk Oligosaccharides Regional Analysis and Outlook
8.4. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) by Country (2021-2032)
8.4.1. China Human Milk Oligosaccharides Regional Analysis and Outlook
8.4.2. Japan Human Milk Oligosaccharides Regional Analysis and Outlook
8.4.3. India Human Milk Oligosaccharides Regional Analysis and Outlook
8.4.4. South Korea Human Milk Oligosaccharides Regional Analysis and Outlook
8.4.5. Australia Human Milk Oligosaccharides Regional Analysis and Outlook
8.4.6. South East Asia Human Milk Oligosaccharides Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Human Milk Oligosaccharides Regional Analysis and Outlook
8.5. South America Human Milk Oligosaccharides Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Human Milk Oligosaccharides Regional Analysis and Outlook
8.5.2. Argentina Human Milk Oligosaccharides Regional Analysis and Outlook
8.5.3. Rest of South America Human Milk Oligosaccharides Regional Analysis and Outlook
8.6. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Human Milk Oligosaccharides Regional Analysis and Outlook
8.6.2. Africa Human Milk Oligosaccharides Regional Analysis and Outlook
Chapter 9. North America Human Milk Oligosaccharides Analysis and Outlook
9.1. North America Human Milk Oligosaccharides Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Human Milk Oligosaccharides Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Human Milk Oligosaccharides Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Human Milk Oligosaccharides Revenue (USD Million) by Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Chapter 10. Europe Human Milk Oligosaccharides Analysis and Outlook
10.1. Europe Human Milk Oligosaccharides Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Human Milk Oligosaccharides Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Human Milk Oligosaccharides Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Human Milk Oligosaccharides Revenue (USD Million) by Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Chapter 11. Asia Pacific Human Milk Oligosaccharides Analysis and Outlook
11.1. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) by Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Chapter 12. South America Human Milk Oligosaccharides Analysis and Outlook
12.1. South America Human Milk Oligosaccharides Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Human Milk Oligosaccharides Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Human Milk Oligosaccharides Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Human Milk Oligosaccharides Revenue (USD Million) by Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Chapter 13. Middle East and Africa Human Milk Oligosaccharides Analysis and Outlook
13.1. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) by Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Chapter 14. Human Milk Oligosaccharides Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Abbott Laboratories
BASF SE
Biosynth Carbosynth
CHR Hansen A/S
Dextra Laboratories
DuPont de Nemours Inc
Elicityl S.A
Gnubiotics Sciences S.A
Inbiose N.V
Nestle S.A.
Royal DSM N.V.
Royal Friesland Campina N.V
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Human Milk Oligosaccharides Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Human Milk Oligosaccharides Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Human Milk Oligosaccharides Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Human Milk Oligosaccharides Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Human Milk Oligosaccharides Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Human Milk Oligosaccharides Market Share (%) By Regions (2021-2032)
Table 12 North America Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Table 15 South America Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Table 17 North America Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Table 18 North America Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Table 19 North America Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Table 26 South America Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Table 27 South America Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Table 28 South America Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Human Milk Oligosaccharides Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Human Milk Oligosaccharides Market Share (%) By Regions (2023)
Figure 6. North America Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 12. France Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 12. China Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 14. India Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Human Milk Oligosaccharides Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Human Milk Oligosaccharides Revenue (USD Million) By Product (2021-2032)
By Type
2’ FL
3’ FL
3’ SL
6’ SL
By Application
Infant Formula
Functional Food & Beverages
Food Supplements
Others
By Concentration
Neutral
Acidic
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Human Milk Oligosaccharides Market Size is valued at $282.3 Million in 2024 and is forecast to register a growth rate (CAGR) of 15.6% to reach $900.3 Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, BASF SE, Biosynth Carbosynth, CHR Hansen A/S, Dextra Laboratories, DuPont de Nemours Inc, Elicityl S.A, Gnubiotics Sciences S.A, Inbiose N.V, Nestle S.A., Royal DSM N.V., Royal Friesland Campina N.V
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume